JP2015529198A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529198A5
JP2015529198A5 JP2015528571A JP2015528571A JP2015529198A5 JP 2015529198 A5 JP2015529198 A5 JP 2015529198A5 JP 2015528571 A JP2015528571 A JP 2015528571A JP 2015528571 A JP2015528571 A JP 2015528571A JP 2015529198 A5 JP2015529198 A5 JP 2015529198A5
Authority
JP
Japan
Prior art keywords
compound
immunogenic carrier
conjugate
protein
nhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015528571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015529198A (ja
JP6131415B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/055724 external-priority patent/WO2014031600A1/en
Publication of JP2015529198A publication Critical patent/JP2015529198A/ja
Publication of JP2015529198A5 publication Critical patent/JP2015529198A5/ja
Application granted granted Critical
Publication of JP6131415B2 publication Critical patent/JP6131415B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015528571A 2012-08-21 2013-08-20 イムノアッセイに使用するためのクエチアピンのハプテン Active JP6131415B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261691462P 2012-08-21 2012-08-21
US61/691,462 2012-08-21
PCT/US2013/055724 WO2014031600A1 (en) 2012-08-21 2013-08-20 Haptens of quetiapine for use in immunoassays

Publications (3)

Publication Number Publication Date
JP2015529198A JP2015529198A (ja) 2015-10-05
JP2015529198A5 true JP2015529198A5 (https=) 2016-04-14
JP6131415B2 JP6131415B2 (ja) 2017-05-24

Family

ID=49081009

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015528571A Active JP6131415B2 (ja) 2012-08-21 2013-08-20 イムノアッセイに使用するためのクエチアピンのハプテン

Country Status (10)

Country Link
US (1) US9304126B2 (https=)
EP (2) EP3305784B1 (https=)
JP (1) JP6131415B2 (https=)
CN (2) CN107266432B (https=)
AU (2) AU2013305935B2 (https=)
CA (1) CA2882557C (https=)
ES (2) ES2822907T3 (https=)
PL (2) PL3305784T3 (https=)
PT (2) PT2888257T (https=)
WO (1) WO2014031600A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2882562C (en) 2012-08-21 2019-08-27 Eric Hryhorenko Antibodies to aripiprazole and use thereof
ES2788716T3 (es) 2012-08-21 2020-10-22 Janssen Pharmaceutica Nv Anticuerpos para haptenos de quetiapina y uso de los mismos
ES2822907T3 (es) * 2012-08-21 2021-05-05 Janssen Pharmaceutica Nv Haptenos de quetiapina para su uso en inmunoensayos
US9494608B2 (en) 2012-08-21 2016-11-15 Janssen Pharmaceutica Nv Antibodies to olanzapine and use thereof
CN104736565B (zh) 2012-08-21 2019-03-12 詹森药业有限公司 利培酮半抗原的抗体及其用途
ES2652641T3 (es) 2012-08-21 2018-02-05 Janssen Pharmaceutica Nv Haptenos de aripiprazol y su uso en inmunoensayos
ES2978909T3 (es) 2012-08-21 2024-09-23 Janssen Pharmaceutica Nv Anticuerpos contra haptenos de aripiprazol y uso de los mismos
EP3462173B1 (en) 2012-08-21 2021-03-31 Janssen Pharmaceutica NV Antibodies to risperidone and use thereof
CA2882490A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone and use thereof
ES2654413T3 (es) 2012-08-21 2018-02-13 Janssen Pharmaceutica, N.V. Anticuerpos a quetiapina y uso de los mismos
JP2015529199A (ja) 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス,インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
JP6389177B2 (ja) 2012-08-21 2018-09-12 ヤンセン ファーマシューティカ エヌ.ベー. オランザピンハプテンに対する抗体及びその使用
US10775365B2 (en) 2015-02-20 2020-09-15 Idexx Laboratories, Inc. Homogenous immunoassay with compensation for background signal
CN108431040B (zh) 2015-12-17 2022-07-26 詹森药业有限公司 利培酮的抗体及其用途
EP3390455A1 (en) 2015-12-17 2018-10-24 Janssen Pharmaceutica NV Antibodies to quetiapine and use thereof
AU2018351349B2 (en) 2017-10-19 2025-08-14 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
JP7311620B2 (ja) 2019-03-08 2023-07-19 メビオン・メディカル・システムズ・インコーポレーテッド 粒子線治療システムのためのコリメータおよびエネルギーデグレーダ
CN111808046B (zh) * 2020-06-30 2022-11-11 杭州同舟生物技术有限公司 一种喹硫平人工半抗原、人工抗原及其制备方法和应用
CN116354904B (zh) * 2023-04-26 2023-08-01 北京丹大生物技术有限公司 一种喹硫平衍生物半抗原、抗原、抗喹硫平抗体及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
DK0582368T3 (da) 1992-05-29 2001-02-05 Lilly Co Eli Thienobenzodiazepinderivater til behandling af forstyrrelser i centralnervesystemet
US6034078A (en) 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
US5395933A (en) 1992-08-07 1995-03-07 Eastman Kodak Company Carbamazepine hapten analogues
US6958156B2 (en) 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
US7193065B2 (en) * 2001-07-13 2007-03-20 Roche Diagnostics Operations, Inc. Protease inhibitor conjugates and antibodies useful in immunoassay
AU2003217936A1 (en) 2002-03-28 2003-10-13 Eli Lilly And Company Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
AU2003264915A1 (en) 2002-08-05 2004-02-25 Eli Lilly And Company Piperazine substituted aryl benzodiazepines
ES2335589T3 (es) * 2003-09-23 2010-03-30 Fermion Oy Preparacion de quetiapina.
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
FR2878850B1 (fr) * 2004-12-02 2008-10-31 Cis Bio Internat Sa Derives de l'inositol-1-phosphate
RU2010116351A (ru) * 2007-09-27 2012-05-20 Новартис АГ (CH) Мониторинг лекарственных средств
US20100069356A1 (en) 2008-09-17 2010-03-18 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
CN102245605B (zh) 2008-10-14 2016-01-27 阿斯利康(瑞典)有限公司 用于治疗细菌感染的稠合、螺环杂芳族化合物
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
CN107714703A (zh) * 2009-12-31 2018-02-23 凯姆制药公司 喹硫平的氨基酸缀合物、其制备和使用方法
EP3476218A1 (en) * 2010-03-11 2019-05-01 Kempharm, Inc. Fatty acid conjugates of quetiapine, process for making and using the same
US8088594B2 (en) 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ctx1bおよび54−デオキシ−ctx1bを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
NZ722096A (en) 2011-12-15 2016-11-25 Alkermes Pharma Ireland Ltd Prodrugs of secondary amine compounds
ES2822907T3 (es) * 2012-08-21 2021-05-05 Janssen Pharmaceutica Nv Haptenos de quetiapina para su uso en inmunoensayos

Similar Documents

Publication Publication Date Title
JP2015529198A5 (https=)
JP2015529197A5 (https=)
JP2015532645A5 (https=)
EP4253075A3 (en) N,n'-diarylurea derivative, manufacturing method thereof, and thermosensitive recording material using same
JP2015527363A5 (https=)
JP2017222671A5 (https=)
BR112014029578A2 (pt) composto heterocíclico fundido
UY35854A (es) Métodos para la conjugación de oxima con polipéptidos ceto-modificados
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
BR112015032689A2 (pt) composto heterocíclico fundido e uso em controle de pragas do mesmo
ES2571483T3 (es) Producto intermedio para producir un éster de ácido sulfónico cíclico
NO20084278L (no) Bezothiazol derivatives as beta2 adrenoreceptor agonists
BR112014021993A2 (pt) detecção da variação de nucleotídeo em sequência de ácido nucleico alvo através de ensaio de clivagem e extensão de pto
IL291939B (en) Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid
BR112018070363A2 (pt) derivados de tetraidroisoquinolina
BRPI0922972A8 (pt) Processo de preparação de ésteres ativados, bem como sal de diciclo–hexilamina
CY1123757T1 (el) Διεργασια για παρασκευη ενωσεων καρβοξαμιδιων ινδολης
EA201201127A1 (ru) Способ получения небиволола
BRPI0606676A2 (pt) processos para a preparação de derivados de ácido 4-(fenóxi-5-metil-pirimidin-4-ilóxi)piperidina-1-carboxì lico e compostos relacionados
PH12015501636B1 (en) Method for preparing 1-(4-(4-(3,4 - dichloro -2- fluorophenylamino)-7- methoxyquinazolin -6- yloxy) piperidin -1-yl) prop-2-en-1-one
WO2013132065A3 (de) Mikromechanisches messelement und verfahren zur herstellung eines mikromechanischen messelements
DK1763586T3 (da) Ny sekvens til forbedring af ekspressionen af nukleinsyre
EA200971019A1 (ru) Способы получения (r)-2-метилпирролидина и (s)-2-метилпирролидина и их солей винной кислоты
EA201691510A1 (ru) Новые способы разделения горохового белка
BR112015021072A2 (pt) processo de preparação de um monotriflato de isohexídeo, composto químico, processo para fabricação de um composto derivado de um monotriflato de isohexídeo, e, composto derivado